[Clinical examination of 3-alpha-phenylpropyl-5-beta-diethyl-aminoethyl-1,2,4-oxadiazole and its influence on gastric acidity].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D004724:Endoscopy; D005260:Female; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000187:drug effects*; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy; D007419:Intestinal Secretions / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010069:Oxadiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy; D013270:Stomach / Q000187:drug effects
D000700:Analgesics; D010069:Oxadiazoles; D010276:Parasympatholytics
Klinische Prüfung von 3-alpha-Phenyl-5-beta-diaethylaminoaethyl-1,2,4-oxadiazol und seine Wirkung auf die Aciditätsverhältnisse mim Magen.